Cambridge Biomedical Inc – Trademark Portfolio
Entity Type: 03
Cambridge Biomedical Inc holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SCIENCE AND SERVICE, CAMBRIDGE BIOMEDICAL, and CUSTOM SOLUTIONS FOR LIFE SCIENCE COMPANIES. The owner is based in Brighton, MA.
1320 Soldiers Field Road
Brighton, MA 02135
Showing of trademarks Trademarks
Trademark Classifications
Cambridge Biomedical Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Cambridge Biomedical Inc have?
Cambridge Biomedical Inc has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 5 cancelled.
What trademark classes does Cambridge Biomedical Inc file in?
Cambridge Biomedical Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Cambridge Biomedical Inc's most well-known trademarks?
Cambridge Biomedical Inc's registered trademark portfolio includes well-known marks such as SCIENCE AND SERVICE, CAMBRIDGE BIOMEDICAL, and CUSTOM SOLUTIONS FOR LIFE SCIENCE COMPANIES. These are among 4 currently registered trademarks in the portfolio.
What is Cambridge Biomedical Inc's trademark registration success rate?
Cambridge Biomedical Inc has a 44% trademark registration rate, with 4 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.